Chapter 11.3
Sclerosing Cholangitis
Konstantinos N. Lazaridis,
Nicholas F. LaRusso,
Konstantinos N. Lazaridis
Search for more papers by this authorNicholas F. LaRusso
Search for more papers by this authorKonstantinos N. Lazaridis,
Nicholas F. LaRusso,
Konstantinos N. Lazaridis
Search for more papers by this authorNicholas F. LaRusso
Search for more papers by this authorBook Editor(s):Juan Rodés MD,
Jean-Pierre Benhamou MD,
Andres T. Blei MD,
Jürg Reichen MD,
Mario Rizzetto MD,
Juan Rodés MD
Director General, Hospital Clinic; Professor of Medicine, University of Barcelona, Barcelona, Spain
Search for more papers by this authorJean-Pierre Benhamou MD
Professor of Hepatology, Université Denis Diderot Paris 7, Assistance Publique — Hôpitaux de Paris and Inserm U773, Service d'Hépatologie, Hôpital Beaujon, Clichy, France
Search for more papers by this authorAndres T. Blei MD
Professor of Medicine and Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Search for more papers by this authorJürg Reichen MD
Professor of Medicine, University of Bern; Chief of Hepatology, University Hospital, Bern, Switzerland
Search for more papers by this authorMario Rizzetto MD
Professor of Gastroenterology, University of Turin, Turin, Italy
Search for more papers by this authorFirst published: 18 June 2007
References
- Bambha K, Kim WR, Talwalkar J et al. (2003) Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 125, 1364–1369.
- Kim WR, Therneau TM, Wiesner RH et al. (2000) A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 75, 688–694.
- MacFaul GR, Chapman RW (2005) Sclerosing cholangitis. Curr Opin Gastroenterol 21, 348–353.
- Gossard AA, Angulo P, Lindor KD (2005) Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis. Am J Gastroenterol 100, 1330–1333.
- Quigley EMM, LaRusso NF, Ludwig J et al. (1983) Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 85, 1160–1165.
- Bergquist A, Lindberg G, Saarinen S et al. (2005) Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J Hepatol 42, 252–256.
- Chapman RW, Varghese Z, Gaul R et al. (1983) Association of primary sclerosing cholangitis with HLA-B8. Gut 24, 38–41.
- Donaldson PT, Doherty DG, Hayllar KM et al. (1991) Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 13, 701–706.
- Mitchell SA, Grove J, Spurkland A et al. (2001) Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut 49, 288–294.
- Satsangi J, Chapman RW, Haldar N et al. (2001) A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology 121, 124–130.
- Norris S, Kondeatis E, Collins R et al. (2001) Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism. Gastroenterology 120, 1475–1482.
- Eri R, Jonsson JR, Pandeya N et al. (2004) CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis. Genes Immun 5, 444–450.
- LaRusso NF, Wiesner RH, Ludwig J et al. (1988) Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 95, 1036–1042.
- Palmer KR, Duerden BJ, Holdworth CD (1980) Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery. Gut 21, 851–854.
- Ludwig J, Barham SS, LaRusso NF et al. (1981) Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis or chronic ulcerative colitis. Hepatology 1, 632–640.
- Panasiuk A, Prokopowicz D, Zak J et al. (2004) Lymphocyte sub-populations in peripheral blood in primary sclerosing cholangitis. Hepatogastroenterology 51, 1289–1291.
- Thorpe MEC, Scheuer PJ, Sherlock S (1967) Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. Gut 8, 435–448.
- Ahnen DJ (1996) Controlled clinical trials: the controls are the key. Gastroenterology 110, 628–630.
- Gohlke F, Lohse AW, Dienes HP et al. (1996) Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 24, 699–705.
- LaRusso NF, Wiesner RH, Ludwig J et al. (1984) Primary sclerosing cholangitis. N Engl J Med 310, 899–903.
- Angulo P, Peter JB, Gershwin ME et al. (2000) Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol 32, 182–187.
- Talwalkar JA, Angulo P, Johnson CD et al. (2004) Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis. Hepatology 40, 39–45.
- Vitellas KM, El-Dieb A, Vaswani KK et al. (2002) MR cholangiopancreatography in patients with primary sclerosing cholangitis: interobserver variability and comparison with endoscopic retrograde cholangiopancreatography. Am J Roentgenol 179, 399–407.
- Ludwig J, Wiesner RH, LaRusso NF (1988) Idiopathic adulthood ductopenia: a cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol 7, 193–199.
- Bjornsson E, Lindqvist-Ottosson J, Asztely M et al. (2004) Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol 99, 502–508.
- Buckels DC, Lindor KD, LaRusso NF et al. (2002) In primary sclerosing cholangitis, gallbladder polyps are frequently malignant. Am J Gastroenterol 97, 1138–1142.
- Lazaridis KN, Gores GJ (2005) Cholangiocarcinoma. Gastroenterology 128, 1655–1667.
- Nichols JC, Gores GJ, LaRusso NF et al. (1993) Diagnostic role of serum CA 19–9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 68, 874–879.
- Chalasani N, Baluyut A, Ismail A et al. (2000) Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 31, 7–11.
- Kipp BR, Stadheim LM, Halling SA et al. (2004) A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 99, 1675–1681.
- Baron TH, Harewood GC, Rumalla A et al. (2004) A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol 2, 214–219.
- Heimbach JK, Haddock MG, Alberts SR et al. (2004) Transplantation for hilar cholangiocarcinoma. Liver Transpl 10, S65–68.
- Sudan D, DeRoover A, Chinnakotla S et al. (2002) Radiochemo-therapy and transplantation allow long-term survival for nonre-sectable hilar cholangiocarcinoma. Am J Transplant 2, 774–779.
- Lindor KD (1997) Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. N Engl J Med 336, 691–695.
- Mitchell SA, Bansi DS, Hunt N et al. (2001) A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 121, 900–907.
- Harnois DM, Angulo P, Jorgensen RA et al. (2001) High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. Am J Gastroenterol 96, 1558–1562.
- Tung BY, Emond MJ, Haggitt RC et al. (2001) Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 134, 89–95.
- Pitt HA, Thompson HH, Tompkins RK et al. (1982) Primary sclerosing cholangitis: results of an aggressive surgical approach. Ann Surg 196, 259–266.
- Cameron JL, Pitt HA, Zinner MJ et al. (1988) Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis. Ann Surg 207, 614–620.
- Kartheuser AH, Dozois RR, LaRusso NF et al. (1996) Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy. Mayo Clin Proc 71, 748–756.
- Cangemi JR, Wiesner RH, Beaver SJ et al. (1989) Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. Gastroenterology 96, 790–794.
- Penna C, Dozois R, Tremaine W et al. (1996) Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 38, 234–239.
- Loftus EV, Jr, Aguilar HI, Sandborn WJ et al. (1998) Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 27, 685–690.
- Graziadei IW, Wiesner RH, Marotta PJ et al. (1999) Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 30, 1121–1127.
